{"transactions":[{"id":4098453,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":55688,"kind":"person","name":"WEIL A LORNE","position":1,"cik":"0000921873","reported_name":"WEIL A LORNE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":170275,"kind":"organization","name":"Hydra LAC, LLC","position":2,"cik":"0001723195","reported_name":"Hydra LAC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2018-01-17T17:35:11.000Z","date":"2018-01-15","kind":"other","acquired":false,"shares":132158,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 132,158 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 132,158 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares of common stock held by the Sponsor Affiliate. The shares held by the Sponsor Affiliate are beneficially owned by A. Lorne Weil, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate. Mr. Weil owns all of the membership interests in the Sponsor Affiliate. Mr. Weil disclaims beneficial ownership over any securities owned by the Sponsor Affiliate in which he does not have any pecuniary interest."}],"balance_after":867842,"source":{"system":"sec-edgar","filing":"0001615774-18-000388","document":"s108741_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921873/000161577418000388/s108741_form4.xml","form_type":"4"}},{"id":4098452,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":55688,"kind":"person","name":"WEIL A LORNE","position":1,"cik":"0000921873","reported_name":"WEIL A LORNE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":170275,"kind":"organization","name":"Hydra LAC, LLC","position":2,"cik":"0001723195","reported_name":"Hydra LAC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2018-01-17T17:35:11.000Z","date":"2018-01-15","kind":"other","acquired":false,"shares":40645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 40,645 shares held by Mr. Weil were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 40,645 shares held by Mr. Weil were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."}],"balance_after":266900,"source":{"system":"sec-edgar","filing":"0001615774-18-000388","document":"s108741_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921873/000161577418000388/s108741_form4.xml","form_type":"4"}},{"id":4143073,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":55688,"kind":"person","name":"WEIL A LORNE","position":1,"cik":"0000921873","reported_name":"WEIL A LORNE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":170275,"kind":"organization","name":"Hydra LAC, LLC","position":2,"cik":"0001723195","reported_name":"Hydra LAC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2017-12-05T18:56:57.000Z","date":"2017-12-05","kind":"other","acquired":false,"shares":169517,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 169,517 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\"), were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 169,517 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\"), were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 132,159 shares held by the Sponsor Affiliate that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares of common stock held by the Sponsor Affiliate. The shares held by the Sponsor Affiliate are beneficially owned by A. Lorne Weil, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate. Mr. Weil owns all of the membership interests in the Sponsor Affiliate. Mr. Weil disclaims beneficial ownership over any securities owned by the Sponsor Affiliate in which he does not have any pecuniary interest."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001144204-17-062471","document":"tv480821_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921873/000114420417062471/tv480821_4.xml","form_type":"4"}},{"id":4143072,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":55688,"kind":"person","name":"WEIL A LORNE","position":1,"cik":"0000921873","reported_name":"WEIL A LORNE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":170275,"kind":"organization","name":"Hydra LAC, LLC","position":2,"cik":"0001723195","reported_name":"Hydra LAC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2017-12-05T18:56:57.000Z","date":"2017-12-05","kind":"other","acquired":false,"shares":187166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 187,166 shares held by Mr. Weil were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As contemplated by the securities subscription agreement between such reporting person and the Company, 187,166 shares held by Mr. Weil were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 40,645 shares held by Mr. Weil that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised."}],"balance_after":307545,"source":{"system":"sec-edgar","filing":"0001144204-17-062471","document":"tv480821_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921873/000114420417062471/tv480821_4.xml","form_type":"4"}}]}